TGA cancels FatBlaster Max listing

The product’s weight loss claims allegedly breached legislation, though its sponsor will appeal the decision The TGA has cancelled the listed complementary medicine FatBlaster Max (AUST L 348163) from the ARTG for alleged breaches of the Therapeutic Goods Act. Sponsor Cat Media had not included weight loss or body fat loss in the list of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Priceline Pharmacy unveils new concept store
Next World news wrapup: 19 May 2022